Difference between revisions of "Ibandronate (Boniva)"
m |
Warner-admin (talk | contribs) m (Text replacement - "manufacturer. Instead" to "manufacturer. Instead") |
||
| Line 6: | Line 6: | ||
<br>Extravasation: no information | <br>Extravasation: no information | ||
| − | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. | + | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref> |
==Patient drug information== | ==Patient drug information== | ||
Revision as of 16:25, 3 December 2017
Also known as Ai Ben, Bandrobon, Bandrone, Bondenza, Bondronat, Bonviva, Femorel, ibandronate sodium, ibandronic acid, Jia Nuo Shun.
General information
Class/mechanism: Bisphosphonate, inhibits osteoclast activity, dissolution of hydroxyapatite crystals, and bone resorption/turnover.[1][2][3][4][5]
Route: PO, IV
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Patient drug information
- Patient counseling information can be found on page 17-21 of the Ibandronate (Boniva) package insert[1]
- Patient counseling information can be found on page 18-21 of the Ibandronate injection (Boniva injection) package insert[3]
- Ibandronate (Boniva) patient drug information (UpToDate)[6]
References
- ↑ 1.0 1.1 1.2 Ibandronate (Boniva) package insert
- ↑ Ibandronate (Boniva) package insert (locally hosted backup)
- ↑ 3.0 3.1 Ibandronate injection (Boniva injection) package insert
- ↑ Ibandronate injection (Boniva injection) package insert (locally hosted backup)
- ↑ Boniva manufacturer's website
- ↑ Ibandronate (Boniva) patient drug information (UpToDate)